IL6 and invasive breast carcinoma: However, anther investigation involving 55 female patients with invasive breast cancer demonstrated that the individuals with IL-6 ≥10.0 pg/ml had poorer overall survival compared with those with IL-6 <10.0 pg/ml (127).